CoChat

Drug-Induced Kidney Stones and Crystalline Nephropathy: Pathophysiology, Prevention and Treatment

The DOI matches its Crossref record; 482 of the 482 references it cites were found in a registry or an index.

Abstract

Drug-induced calculi represent 1-2% of all renal calculi. The drugs reported to produce calculi may be divided into two groups. The first one includes poorly soluble drugs with high urine excretion that favour crystallisation in the urine. Among them, drugs used for the treatment of patients with human immunodeficiency, namely atazanavir and other protease inhibitors, and sulphadiazine used for the treatment of cerebral toxoplasmosis, are the most frequent causes. Besides these drugs, about 20 other molecules may induce nephrolithiasis, such as ceftriaxone or ephedrine-containing preparations in subjects receiving high doses or long-term treatment. Calculi analysis by physical methods including infrared spectroscopy or X-ray diffraction is needed to demonstrate the presence of the drug or its metabolites within the calculi. Some drugs may also provoke heavy intra-tubular crystal precipitation causing acute renal failure. Here, the identification of crystalluria or crystals within the kidney tissue in the case of renal biopsy is of major diagnostic value. The second group includes drugs that provoke the formation of urinary calculi as a consequence of their metabolic effects on urinary pH and/or the excretion of calcium, phosphate, oxalate, citrate, uric acid or other purines. Among such metabolically induced calculi are those formed in patients taking uncontrolled calcium/vitamin D supplements, or being treated with carbonic anhydrase inhibitors such as acetazolamide or topiramate. Here, diagnosis relies on a careful clinical inquiry to differentiate between common calculi and metabolically induced calculi, of which the incidence is probably underestimated. Specific patient-dependent risk factors also exist in relation to urine pH, volume of diuresis and other factors, thus providing a basis for preventive or curative measures against stone formation.

Overview

Integrity signals

Registry

Crossref · 10.1007/s40265-017-0853-7

Cites

482 of 482 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Items 201–400 of 482

Research works printed but not linked: 18

  1. Réveillaud RJ, Daudon M. Les lithiases urinaires médicamenteuses. Sémin Uro-Néphrol. 1986;12:14–39.
  2. Nguyen Quy D, Daudon M. Infrared and Raman spectra of calculi. Paris: Elsevier; 1997.
  3. Daudon M. Méthodes d’analyse des calculs et des cristaux urinaires. Classification morpho-constitutionnelle des calculs. In: Jungers P, Daudon M, Le Duc A, editors. Lithiase urinaire. Paris: Flammarion Médecine-Sciences; 1989. p. 35–113.
  4. Asper R. Iatrogenic urinary calculi: detection and identification by X-ray diffraction. Clin Chem. 1986;24:767–8.
  5. Daudon M, Estepa L, Viard JP, et al. Indinavir crystalluria in HIV-positive patients treated with indinavir sulfate. In: Rodgers AL, Hibbert BE, Hess B, Khan SR, Preminger GM, editors. Urolithiasis 2000, vol. I. Rondebosh: University of Cape Town; 2000. p. 335–7.
  6. Daudon M, Jungers P, Lacour B. Intérêt clinique de l’étude de la cristallurie. Ann Biol Clin. 2004;62:379–93.
  7. Daudon M, Estepa L, Labro B, et al. Infrared analysis of urinary calculi from animals [in French]. Eurobiol. 1998;236:243–55.
  8. Hammarsten G, Helldorff I, Magnusson W, et al. Dubbelsidiga njurstenar av kiselsyra efter bruk av silikathaltigt antacidum. Svensk Lakartiduing. 1953;50:1242–6.
  9. Hammarsten G. Terapi-inducerade urinvOagskonkrement. Opuscula Medica. 1958;3(1):19–22.
  10. Gaultier M, Bismuth C, Efthymiou ML, et al. Néphropathie tubulo-interstitielle aiguë au cours d’une intoxication par la glafénine. Nouv Presse Méd. 1975;1:3125.
  11. Volpe P, Peyrottes A, Lammle M, et al. Calcul urinaire de xanthine chez un patient porteur d’un syndrome de Lesch Nyhan. A propos d’un cas. Prog Urol. 1997;7(1):74–7.
  12. Cifuentes I, Bellanato J, Arquillué A, et al. Presencia de acido oxolinico en un calculo renal. Arch Esp Urol. 1986;39(5):369–73.
  13. Menzi P. Furadantin-Stein in einer Ureterozele. Helvet Chir. 1970;37(4/5):538–40.
  14. Zupancic M, Bukovec P. Complexation of magnesium (II) with ciprofloxacin and norfloxacin. Act Pharm. 1996;46:221–8.
  15. Parent X, Schieffer F. Felbamate crystalluria [in French]. Ann Biol Clin (Paris). 2010;68(5):609–13.
  16. Golematis B, Hatzitheofilou C, Dreiling DA, et al. The incidence of urolithiasis in pepticulcer patients. Am J Gastroenterol. 1977;68:367–71.
  17. Navas P, Grasset D. Anurie par lithiase urétérale urique bilatérale au cours d’un traitement par l’Amplivix. J Urol Néphrol. 1973;79:466–9.
  18. Matzkies F. Wirkungen und Nebenwirkungen von Benzbromaron bei der Initialbehandlung von Hyperurikämie und Gicht. Ergebnisse eines Feldversuches mit 3899 Patienten. Fortschr Med. 1978;96(32):1619–21.

Cited by

See all 210

Metadata

Authors
Daudon, M., Frochot, V., Bazin, D., & Jungers, P.
Affiliations
  • Inserm (FR)
  • Centre National de la Recherche Scientifique (FR)
  • Hôpital Necker-Enfants Malades (FR)
Corresponding author
Daudon, Michel
Venue
Drugs
Published
2017-12-20
Volume
78
Issue
2
Pages
163-201
ISSN
  • 0012-6667 (ISSN-L)
  • 1179-1950
OpenAlex
W2781125041
Cited by
191
References
481
Citations by year
2026: 15 · 2025: 24 · 2024: 28 · 2023: 28 · 2022: 36 · 2021: 24 · 2020: 19 · 2019: 10 · 2018: 6 · 2017: 1
FWCI
1.80
Type
journal article
Language
en
Open access
closed
Locations
  • Drugs (publishedVersion)
  • PubMed (publishedVersion)
  • HAL (submittedVersion)
Topics
  • Health Sciences › Medicine › Urology › Kidney Stones and Urolithiasis Treatments
  • Health Sciences › Medicine › Nephrology › Nephrotoxicity and Medicinal Plants
  • Health Sciences › Medicine › Nephrology › Acute Kidney Injury Research
Keywords
drug-induced nephrolithiasis, crystalline nephropathy, kidney stones, urinary calculi, crystalluria, atazanavir, protease inhibitors, sulfadiazine, ceftriaxone, ephedrine, acute kidney injury, urine pH, calcium and vitamin D supplementation, carbonic anhydrase inhibitors, acetazolamide, topiramate, stone prevention, stone composition analysis
MeSH terms
Crystallization, Humans, Kidney Calculi, Risk Factors, Solubility, Acute Kidney Injury, Drug-Related Side Effects and Adverse Reactions, Renal Elimination

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.